The Debate about PBM Rebates Continues

What started out as a way to help many pharmacy benefit managers (PBMs) to control costs has turned into a major sticking point in the health care system: pharmaceutical rebates.

Attention is growing regarding the role that rebates play in actually increasing the price of brand-name drugs, which is adding a heavier burden on health plan enrollees. Calls are growing to jettison rebates altogether. The problem is that insurers often get to keep the rebates and not pass them on to their enrollees.

A study by Benfield, a division of benefit consulting firm Gallagher Benefits, found that 69% of employers surveyed would welcome an alternative to rebates, such as discounts or point-of-sale rebates, in which patient payments reflect a post-rebate price.

Employers acknowledged focusing on rebates as a revenue stream rather than focusing their attention on other important factors such as reducing employee coinsurance or deductible payments, or providing access to the most effective medicines.

The issue of rebates even has the attention of the Trump administration.

When Department of Health and Human Services Secretary Alex Azar testified before the Senate Health Education Labor & Pensions Committee in 2018, he said: “We may need to move toward a system without rebates, where PBMs and drug companies just negotiate fixed-price contracts. Such a system’s incentives, detached from these artificial list prices, would likely serve patients far better, as would a system where PBMs receive no compensation from the very pharma companies they’re supposed to be negotiating against.”

How rebates work

Drug rebates are redeemed after the transaction has taken place, but it’s not the end user (the plan enrollee) who is receiving the rebates. Instead, the PBM, the insurer or sometimes the employer receives the rebate.

The big debate is that these rebates do nothing to help the enrollee, who is often having to pay a higher cost-sharing burden for medications.

Under the current system, drug makers set a list price for their products, then negotiate with some PBMs over how much of a discount they will provide off that list price.

The size of the rebate depends on a number of factors, like how many drugs are used by the health plan enrollees, and how much of the medicine cost is covered under the drug formulary.
Companies that offer bigger rebates are often rewarded with better access, like smaller copayments.

 

What happens if rebates are jettisoned?

Nobody can accurately predict what would happen if rebates were eliminated.

Their elimination could potentially increase expenditures for brand drugs if payers do not find an alternative tool that reduces drug costs (for example, negotiating lower prices to begin with).

A report by Altarum, a not-for-profit health care research and consulting organization, estimated that $89 billion in rebates went to payers in 2016. Altarum found that state Medicaid plans received $32 billion of the total, followed by Medicare Part D plans ($31 billion), commercial health plans ($23 billion), and other payers ($3 billion).

Eliminating rebates will have the most significant effect on patients. Medicare and commercial insurance rebates totaled $54 billion in 2016, according to the Altarum report. The big unknown is exactly how much of that total directly benefited patients and how much flowed to the insurers and the Centers for Medicare & Medicaid Services.

As Drug Prices Skyrocket, This Top 10 List Will Shock You

It’s no secret that the cost of pharmaceuticals is going through the roof. You’ve heard the stories of price-gouging by some companies that have jacked up prices thousands of percent.

Drug costs are starting to weigh heavily on the cost of care, in turn driving up health insurance premiums, which individuals, employees and employers are all feeling. The cost of some medications is so extreme that a single dose may far surpass the total premium paid for coverage.Read More

Telemedicine Improves Outcomes, Saves Money

Recent studies have shown that telemedicine can yield significant savings for group health plans and covered employees – but only if the employees actually use it.

While telemedicine has penetrated the ranks of large employers (96% say they make it available to their employees), 20% of employers say that less than one-tenth of their workers actually use it.Read More

60 Minutes – The Rockford File

60 Minutes: The problem with prescription drug prices

“Every company can make profits, but this is profiteering. This is gouging.”

On Sunday night, 60 Minutes covered what one city did to fight back against high drug prices by exposing an increasing corrupt drug supply chain. Continue the conversation with Tom Emerick, industry-leading consultant for Walmart, Burger King, and BP,  May 15th to see how this type of supply chain corruption affects your business and what you can do about it.

Watch Video
Complimentary Registration

Tout Tax Benefits of Long-term Disability Insurance to Your Staff

One of the most overlooked and undervalued employee benefits is long-term disability insurance. Often, even if the employer offers to cover the low premium, employees don’t sign up.

They think they won’t become disabled or need income replacement, despite some startling statistics: that about 25% of 20-year-olds will become disabled, even if temporarily, before they reach retirement.Read More

Helping Your Staff Get the Most from Their HSA Plans

As more employers adopt high-deductible health plans, which leave their employees with more “skin in the game,” it’s important that you educate them on how to get the most out of the attached health savings accounts.

Unfortunately, your employees may not be using the funds in their HSAs as efficiently as they should, and they could be leaving money on the table. One of the most common ways that happens is spending those funds on inappropriate care or misdiagnosed afflictions. It’s estimated that up to $1 trillion a year is spent on this type of erroneous care.Read More

New Rules Lay Down Law for Group Plans in 2019

In the final rules that the Centers for Medicare and Medicaid Services released for 2019, it also covered annual cost-sharing limits for group plans, rules on SHOP exchanges, and grandfathered plans, among other items we’ve covered earlier.

Here we break down some of the focuses of the 2019 rules:Read More

Maximum Family HSA Contribution Reduced for 2018

One of the unintended consequences of the tax bill that was signed into law by President Trump in December was a change to the HSA contribution limits for 2018, and action needs to be taken for some participants immediately.

As a result of the new tax law, the IRS announced in March that the maximum family contribution to a health savings account for 2018 is being reduced by $50 (from $6,900 to $6,850).Read More

OSHA’s Anti-retaliation Rules for ACA

Do you know that Fed-OSHA has regulations on whistleblowing and employer retaliation under the Affordable Care Act?

The rules set forth procedures and time frames for reporting and processing whistleblower complaints by employees against their employers and expand the instances in which an employee can sue their employer for retaliation under the ACA.Read More

Proposed Regs on Small Business Association Plans Could Invite Fraud

Proposed regulations that would allow small businesses and individuals to band together to purchase group coverage could open up a new era of fraud in U.S. health insurance, according to comments filed by a number of groups.

Former Department of Labor officials, insurance companies and employee advocacy groups sounded the warning in letters to the DOL during the proposed regulations’ comment period, which ended March 6, according to a report by Bloomberg Law.Read More

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Youtube
Consent to display content from Youtube
Vimeo
Consent to display content from Vimeo
Google Maps
Consent to display content from Google